These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8370173)

  • 1. Functional analysis of TCR gamma delta+ T cells in tumour-infiltrating lymphocytes (TIL) of human pancreatic cancer.
    Kitayama J; Atomi Y; Nagawa H; Kuroda A; Mutoh T; Minami M; Juji T
    Clin Exp Immunol; 1993 Sep; 93(3):442-7. PubMed ID: 8370173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma/delta T cell antigen receptors expressed on tumor-infiltrating lymphocytes from patients with solid tumors.
    Nanno M; Seki H; Mathioudakis G; Suzuki R; Itoh K; Ioannides CG; Suzuki S; Chen PF; Platsoucas CD
    Eur J Immunol; 1992 Mar; 22(3):679-87. PubMed ID: 1312472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective lysis of autologous tumor cells by recurrent gamma delta tumor-infiltrating lymphocytes from renal carcinoma.
    Choudhary A; Davodeau F; Moreau A; Peyrat MA; Bonneville M; Jotereau F
    J Immunol; 1995 Apr; 154(8):3932-40. PubMed ID: 7706731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of T cell receptor (TCR)-gamma delta + T cells into human colorectal cancer: flow cytometric analysis of TCR-gamma delta expression in tumour-infiltrating lymphocytes.
    Watanabe N; Hizuta A; Tanaka N; Orita K
    Clin Exp Immunol; 1995 Oct; 102(1):167-73. PubMed ID: 7554384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of gamma/delta T cells in human dysgerminoma and seminoma: roles in autologous tumor killing and granuloma formation.
    Zhao X; Wei YQ; Kariya Y; Teshigawara K; Uchida A
    Immunol Invest; 1995 May; 24(4):607-18. PubMed ID: 7622197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of fresh (uncultured) tumour-infiltrating lymphocytes (TIL) and TIL-derived T cell lines from patients with renal cell carcinoma.
    Mitropoulos D; Kooi S; Rodriguez-Villanueva J; Platsoucas CD
    Clin Exp Immunol; 1994 Aug; 97(2):321-7. PubMed ID: 8050183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer.
    Meng Q; Liu Z; Rangelova E; Poiret T; Ambati A; Rane L; Xie S; Verbeke C; Dodoo E; Del Chiaro M; Löhr M; Segersvärd R; Maeurer MJ
    J Immunother; 2016; 39(2):81-9. PubMed ID: 26849077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell receptor gene rearrangements and cytotoxic activities of clones isolated from tumour-infiltrating lymphocytes (TIL) from melanoma patients.
    Pandolfi F; Boyle LA; Trentin L; Oliva A; Kurnick JT
    Clin Exp Immunol; 1994 Jan; 95(1):141-7. PubMed ID: 8287599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric analysis of tumour-infiltrating lymphocytes in patients with renal cell carcinoma.
    Kowalczyk D; Skorupski W; Kwias Z; Nowak J
    Br J Urol; 1997 Oct; 80(4):543-7. PubMed ID: 9352689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective lysis of the autologous tumor by delta TCS1+ gamma/delta+ tumor-infiltrating lymphocytes from human lung carcinomas.
    Zocchi MR; Ferrarini M; Rugarli C
    Eur J Immunol; 1990 Dec; 20(12):2685-9. PubMed ID: 1702723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
    Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL
    Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-scale expansion in interleukin-2 of tumor-infiltrating lymphocytes from patients with ovarian carcinoma for adoptive immunotherapy.
    Freedman RS; Tomasovic B; Templin S; Atkinson EN; Kudelka A; Edwards CL; Platsoucas CD
    J Immunol Methods; 1994 Jan; 167(1-2):145-60. PubMed ID: 8308273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic and functional analysis of lymphocytes infiltrating paediatric tumours, with a characterization of the tumour phenotype.
    Rivoltini L; Arienti F; Orazi A; Cefalo G; Gasparini M; Gambacorti-Passerini C; Fossati-Bellani F; Parmiani G
    Cancer Immunol Immunother; 1992; 34(4):241-51. PubMed ID: 1311218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumors.
    Hall M; Liu H; Malafa M; Centeno B; Hodul PJ; Pimiento J; Pilon-Thomas S; Sarnaik AA
    J Immunother Cancer; 2016; 4():61. PubMed ID: 27777771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of tumor-specific HLA class I restricted cytotoxicity in tumor infiltrating lymphocytes of advanced breast cancer patients by in vitro stimulation with tumor antigen-pulsed autologous dendritic cells.
    Kass R; Bellone S; Palmieri M; Canè S; Bignotti E; Henry-Tillman R; Hutchins L; Cannon MJ; Klimberg S; Santin AD
    Breast Cancer Res Treat; 2003 Aug; 80(3):275-85. PubMed ID: 14503800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of different culture protocols on the expression of discrete T-cell receptor variable regions in human tumour infiltrating lymphocytes.
    Filgueira L; Zuber M; Merlo A; Harder F; Heberer M; Spagnoli GC
    Eur J Cancer; 1993; 29A(12):1754-60. PubMed ID: 8398305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic characterization of murine tumor-infiltrating T lymphocytes.
    Karpati RM; Banks SM; Malissen B; Rosenberg SA; Sheard MA; Weber JS; Hodes RJ
    J Immunol; 1991 Mar; 146(6):2043-51. PubMed ID: 1672340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated gamma/delta T lymphocytes infiltrating renal cell carcinoma.
    Kowalczyk D; Skorupski W; Kwias Z; Nowak J
    Immunol Lett; 1996 Oct; 53(1):15-8. PubMed ID: 8946212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic potential despite impaired activation pathways in T lymphocytes infiltrating nasopharyngeal carcinoma.
    Ferradini L; Miescher S; Stoeck M; Busson P; Barras C; Cerf-Bensussan N; Lipinski M; von Fliedner V; Tursz T
    Int J Cancer; 1991 Feb; 47(3):362-70. PubMed ID: 1899651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.